Dyne Therapeutics DYN
NASDAQ DYN
$15.20 -0.62 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Other Accumulated Expenses (2019 - 2026)

Updated

Dyne Therapeutics (DYN) posted Other Accumulated Expenses of $29.52 million for Q2 2026, up 163.0% from $11.23 million a year earlier and up 63.6% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Dyne Therapeutics' Other Accumulated Expenses came in at $17.09 million, up 10.9% from FY2024.

  • Annual Other Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 29.0% (FY2020 to FY2025).
  • In prior years, Dyne Therapeutics' Other Accumulated Expenses was $15.4 million in FY2024 (+27.1%), $12.12 million in FY2023 (+9.2%), $11.1 million in FY2022 (-24.8%) and $14.76 million in FY2021 (+208.7%).
  • The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2019.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last four quarters, with growth averaging 71.5% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2021, with growth of 896.5%; the weakest was Q1 2023, with a decline of 54.4%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $18.04 million (Q1 2026), $17.09 million (Q4 2025) and $26.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Dyne Therapeutics 2.62 Bn 2.62 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.52 Mn
Mar 31, 2026 18.04 Mn
Dec 31, 2025 17.09 Mn
Sep 30, 2025 26.92 Mn
Jun 30, 2025 11.23 Mn
Mar 31, 2025 14.84 Mn
Dec 31, 2024 15.40 Mn
Sep 30, 2024 19.38 Mn
Jun 30, 2024 12.72 Mn
Mar 31, 2024 3.85 Mn
Dec 31, 2023 12.12 Mn
Sep 30, 2023 14.22 Mn
Jun 30, 2023 7.63 Mn
Mar 31, 2023 5.05 Mn
Dec 31, 2022 11.10 Mn
Sep 30, 2022 12.04 Mn
Jun 30, 2022 9.28 Mn
Mar 31, 2022 11.07 Mn
Dec 31, 2021 14.76 Mn
Sep 30, 2021 8.15 Mn
API Access

Dyne Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=DYN&period=max&api_key=YOUR_API_KEY